-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Jointown and Dyne Pharmaceuticals signed a strategic agreement for 2022
.
The agreement shows that the two parties will cooperate in various fields such as terminal coverage, e-commerce cooperation, channel expansion, new product development, and brand co-building
.
In the future, more children's health products will reach users through the professional and multi-faceted channel services of Jointown
.
According to data, Dyne Pharmaceuticals is a pharmaceutical company that mainly focuses on the research and development and production of products in the field of children's health.
It owns many star products such as Yikexin, Gaidixin and Yijiaxin
.
Among them, there are 40 special medicines for children, involving 15 categories.
During the 14th Five-Year Plan period, 1~2 new products will be launched every year
.
Kyushu is a company whose core business is the wholesale and retail chain of medicines, medical devices and other products, as well as the production and research and development of medicines and related value-added services
.
It has development advantages in the field of pharmaceutical commercial circulation and pharmaceutical business
.
According to data, as of 2020, Jointown’s business has covered 159,200 primary medical institutions, 9,175 private hospitals, 5,337 chain pharmacies and other physical end customers
.
In this regard, the industry believes that the cooperation between Dyne Pharmaceuticals and such as Jiuzhoutong is expected to realize the rapid opening of the out-of-hospital market and obtain sales channels such as pharmacies and clinics
.
It is understood that with the accelerated reform of the pharmaceutical market in recent years, market competition has further intensified
.
Pharmaceutical companies are all exploring ways to break through
.
Among them, cooperation has long been an indispensable development method for pharmaceutical companies; at the same time, the "industry + business" cooperation model is gradually infiltrating the industry
.
In this context, as one of the well-known pharmaceutical distribution companies in China, Jointown has also cooperated frequently in recent years
.
Since 2022, Jointown has made great moves, actively signed strategic cooperation agreements with a number of pharmaceutical companies, and achieved many strong alliances
.
For example, on February 20, Jointown and Chia Tai Tianqing held a signing ceremony for the opening of strategic cooperation
.
The two parties set up a pre-drug warehouse in Henan Jiuzhoutong, and reached a new year's cooperation consensus and goals in terms of pharmaceutical storage and distribution
.
On February 17, Wohua Medicine and Jointown signed an e-commerce strategic cooperation to carry out nationwide e-commerce business cooperation in the fields of cardiovascular and cerebrovascular, orthopedics, women and children and other fields
.
Wohua Pharma will use Jointown's strong national channel network and control system to introduce branded products into the online sales platform, enrich and expand product marketing channels.
At the same time, Jointown's online and offline supply, promotion and product pricing will be integrated.
, and will effectively reduce channel conflicts
.
On January 28, Jointown signed a three-year strategic cooperation agreement with Johnson & Johnson China's personal health care business.
According to the needs of Johnson & Johnson's personal health care business in China, it matched Jointown's digital retail, brand agency and promotion capabilities, and extensive layout of primary medical care.
Chinese market cooperation
.
To a certain extent, Jointown is promoting its own development through continuous cooperation with other pharmaceutical companies
.
For these cooperations, the industry believes that commercial companies will bring a broader sales market to their products with the help of the mature distribution system and channel terminal layout and development of Jointown
.
By providing development channels for commercial enterprises, Jointown will also win more new market development opportunities for itself
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
The agreement shows that the two parties will cooperate in various fields such as terminal coverage, e-commerce cooperation, channel expansion, new product development, and brand co-building
.
In the future, more children's health products will reach users through the professional and multi-faceted channel services of Jointown
.
According to data, Dyne Pharmaceuticals is a pharmaceutical company that mainly focuses on the research and development and production of products in the field of children's health.
It owns many star products such as Yikexin, Gaidixin and Yijiaxin
.
Among them, there are 40 special medicines for children, involving 15 categories.
During the 14th Five-Year Plan period, 1~2 new products will be launched every year
.
Kyushu is a company whose core business is the wholesale and retail chain of medicines, medical devices and other products, as well as the production and research and development of medicines and related value-added services
.
It has development advantages in the field of pharmaceutical commercial circulation and pharmaceutical business
.
According to data, as of 2020, Jointown’s business has covered 159,200 primary medical institutions, 9,175 private hospitals, 5,337 chain pharmacies and other physical end customers
.
In this regard, the industry believes that the cooperation between Dyne Pharmaceuticals and such as Jiuzhoutong is expected to realize the rapid opening of the out-of-hospital market and obtain sales channels such as pharmacies and clinics
.
It is understood that with the accelerated reform of the pharmaceutical market in recent years, market competition has further intensified
.
Pharmaceutical companies are all exploring ways to break through
.
Among them, cooperation has long been an indispensable development method for pharmaceutical companies; at the same time, the "industry + business" cooperation model is gradually infiltrating the industry
.
In this context, as one of the well-known pharmaceutical distribution companies in China, Jointown has also cooperated frequently in recent years
.
Since 2022, Jointown has made great moves, actively signed strategic cooperation agreements with a number of pharmaceutical companies, and achieved many strong alliances
.
For example, on February 20, Jointown and Chia Tai Tianqing held a signing ceremony for the opening of strategic cooperation
.
The two parties set up a pre-drug warehouse in Henan Jiuzhoutong, and reached a new year's cooperation consensus and goals in terms of pharmaceutical storage and distribution
.
On February 17, Wohua Medicine and Jointown signed an e-commerce strategic cooperation to carry out nationwide e-commerce business cooperation in the fields of cardiovascular and cerebrovascular, orthopedics, women and children and other fields
.
Wohua Pharma will use Jointown's strong national channel network and control system to introduce branded products into the online sales platform, enrich and expand product marketing channels.
At the same time, Jointown's online and offline supply, promotion and product pricing will be integrated.
, and will effectively reduce channel conflicts
.
On January 28, Jointown signed a three-year strategic cooperation agreement with Johnson & Johnson China's personal health care business.
According to the needs of Johnson & Johnson's personal health care business in China, it matched Jointown's digital retail, brand agency and promotion capabilities, and extensive layout of primary medical care.
Chinese market cooperation
.
To a certain extent, Jointown is promoting its own development through continuous cooperation with other pharmaceutical companies
.
For these cooperations, the industry believes that commercial companies will bring a broader sales market to their products with the help of the mature distribution system and channel terminal layout and development of Jointown
.
By providing development channels for commercial enterprises, Jointown will also win more new market development opportunities for itself
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
